Sulfuric Acid

Sulfuric Acid

SCHEMBL2126556

O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[V+4]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
TP53 P04637 1/20 0.40
CA5A P35218 2/20 0.30
CA5B Q9Y2D0 2/20 0.30
KDM4E B2RXH2 1/20 0.30
CYP3A4 P08684 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA4 P22748 1/20 0.30
CA6 P23280 1/20 0.30
CA7 P43166 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4398598 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL4369862 0.94
Sulfuric Acid SCHEMBL187222 0.93 MEN1 (0.50) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL668306 0.88
Sulfuric Acid SCHEMBL40908 0.86
Sulfuric Acid SCHEMBL5481301 0.86 MEN1 (0.46) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL72615 0.86 MEN1 (0.46) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL3538052 0.86
Sulfuric Acid SCHEMBL6013966 0.86 MEN1 (0.46) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL7151702 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11756713-B2 Grain-oriented magnetic steel sheets having chromium-free insulating tension coating, and methods for producing such steel sheets JFE STEEL CORPORATION (JP) 2023-09-12 US claimed
WO-2023087993-A1 ION EXCHANGE LIQUID FILM FLOW BATTERY 西湖大学 2023-05-25 WO claimed
US-20150160149-A1 SENSING MATERIAL FOR GAS SENSOR, GAS SENSOR COMPRISING THE SENSING MATERIAL, METHOD OF PREPARING THE SENSING MATERIAL, AND METHOD OF MANUFACTURING THE GAS SENSOR SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-11 US claimed
EP-0799503-B1 METHOD FOR PRODUCING ELECTRIC ENERGY IN A BIOFUEL-POWERED FUEL CELL SUFUCELL AB (SE) 1999-05-19 EP claimed
EP-4734929-A1 SYSTEM AND METHODS FOR MODIFYING SURFACE PROPERTIES OF KERATIN-CONTAINING SURFACES Edulis Labs Inc. (US) 2026-05-06 EP disclosed
US-20250282621-A1 CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL L IGANDS NANOCORE APS (DK) 2025-09-11 US disclosed
CN-119654236-A Coated metal plate 日本制铁株式会社 2025-03-18 CN disclosed
US-12227625-B2 Composite materials comprising mechanical ligands NANOCORE APS (DK) 2025-02-18 US disclosed
US-12208118-B2 Pharmaceutical compositions for delivery of peptide ANYA BIOPHARM INC. (CN) 2025-01-28 US disclosed
WO-2025006080-A1 SYSTEM AND METHODS FOR MODIFYING SURFACE PROPERTIES OF KERATIN-CONTAINING SURFACES EDULIS LABS INC. (US) 2025-01-02 WO disclosed
US-20240293352-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING VANADIUM SALTS OTTAWA HOSPITAL RESEARCH INSTITUTE (CA) 2024-09-05 US disclosed
US-20240194918-A1 FORWARD OSMOSIS PROCESS TO INCREASE THE CONCENTRATION OF A DILUTE METAL SALT SOLUTION AND RELATED PROCESSES UNIVERSITY OF KANSAS 2024-06-13 US disclosed
US-20090317668-A1 FUEL CELLS ACAL ENERGY LIMITED 2009-12-24 US disclosed
EP-1999811-A2 FUEL CELLS Acal Energy Limited (GB) 2008-12-10 EP disclosed
WO-2007110663-A2 FUEL CELLS ACAL ENERGY LIMITED (GB) 2007-10-04 WO disclosed
US-5932746-A VANADIUM PYROPHOSPHATE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1999-08-03 US disclosed
EP-0799503-B1 METHOD FOR PRODUCING ELECTRIC ENERGY IN A BIOFUEL-POWERED FUEL CELL SUFUCELL AB (SE) 1999-05-19 EP disclosed
EP-0799503-A1 METHOD FOR PRODUCING ELECTRIC ENERGY IN A BIOFUEL-POWERED FUEL CELL SUFUCELL AB (SE) 1997-10-08 EP disclosed
US-5660940-A Method for producing electric energy in a biofuel-powered fuel cell SUFUCELL AB (SE) 1997-08-26 US disclosed
WO-1995017773-A1 METHOD FOR PRODUCING ELECTRIC ENERGY IN A BIOFUEL-POWERED FUEL CELL SUFUCELL AB (SE) 1995-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240293352-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING VANADIUM SALTS HAVCR2, CD4, CD81 MEN1 2939/4885ALDH1A1 3508/4885TSHR 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.